Danmarks Skibskredit A/S
10.3.2021 11:44:46 CET | Globenewswire | Press release
New Final Bond Terms for the Danish Ship Finance A/S Base Prospectus dated 9 July 2020
Danish Ship Finance issues new fixed rate non-callable bullet bond (SMB) with maturity date 1 January 2030.
In connection with the opening of new ISINs under the Danish Ship Finance A/S Base Prospectus dated 9 July 2020, Danish Ship Finance issues new Final Bond Terms.
The Final Bond Terms are stated below.
The Danish Ship Finance A/S Base Prospectus dated 9 July 2020 and the relevant Final Bond Terms are available for download on Danish Ship Finance A/S’ website at http://www.shipfinance.dk/investor-relations/.
| ISIN | Capital Centre | Currency | Opening date | Maturity |
| DK0004132917 | Institute in General | DKK | 12 March 2021 | 1 January 2030 |
Questions may be addressed to Head of Funding, Casper Fries, tel +45 33 33 93 33, IR@skibskredit.dk
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Sanofi Winthrop Industrie28.3.2026 16:00:00 CET | Press release
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Rocket Lab Corporation28.3.2026 11:39:53 CET | Press release
Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency
Vivoryon Therapeutics N.V.28.3.2026 07:00:00 CET | Press release
Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
